Logo image of OZON

Ozon Holdings PLC (OZON) Stock Fundamental Analysis

NASDAQ:OZON - Nasdaq - US69269L1044 - ADR - Currency: USD

11.6  -1.03 (-8.16%)

Premarket: 9.4 -2.2 (-18.97%)

Fundamental Rating

2

Taking everything into account, OZON scores 2 out of 10 in our fundamental rating. OZON was compared to 0 industry peers in the Internet & Direct Marketing Retail industry. OZON may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, OZON is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OZON had negative earnings in the past year.
OZON Yearly Net Income VS EBIT VS OCF VS FCFOZON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 0 5B -5B -10B -15B -20B

1.2 Ratios

Industry RankSector Rank
ROA -21.98%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OZON Yearly ROA, ROE, ROICOZON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 -500 -1K -1.5K -2K

1.3 Margins

Industry RankSector Rank
OM -28.12%
PM (TTM) -30.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OZON Yearly Profit, Operating, Gross MarginsOZON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 0 -10 -20 -30

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for OZON has been increased compared to 1 year ago.
The debt/assets ratio for OZON has been reduced compared to a year ago.
OZON Yearly Shares OutstandingOZON Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 50M 100M 150M 200M
OZON Yearly Total Debt VS Total AssetsOZON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 50B 100B 150B

2.2 Solvency

OZON has an Altman-Z score of 0.72. This is a bad value and indicates that OZON is not financially healthy and even has some risk of bankruptcy.
OZON has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACCN/A
WACCN/A
OZON Yearly LT Debt VS Equity VS FCFOZON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 0 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.92 indicates that OZON should not have too much problems paying its short term obligations.
OZON has a Quick Ratio of 1.67. This is a normal value and indicates that OZON is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.67
OZON Yearly Current Assets VS Current LiabilitesOZON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 20B 40B 60B 80B 100B

More info and screens

6

3. Growth

3.1 Past

OZON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.26%.
OZON shows a strong growth in Revenue. In the last year, the Revenue has grown by 70.96%.
OZON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.44% yearly.
EPS 1Y (TTM)-136.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-217.21%
Revenue 1Y (TTM)70.96%
Revenue growth 3Y67.44%
Revenue growth 5YN/A
Sales Q2Q%84.93%

3.2 Future

The Earnings Per Share is expected to decrease by -21.70% on average over the next years. This is quite bad
The Revenue is expected to grow by 62.13% on average over the next years. This is a very strong growth
EPS Next Y-182.2%
EPS Next 2Y-87.19%
EPS Next 3Y-46.97%
EPS Next 5Y-21.7%
Revenue Next Year74.83%
Revenue Next 2Y72.82%
Revenue Next 3Y64.59%
Revenue Next 5Y62.13%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
OZON Yearly Revenue VS EstimatesOZON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T
OZON Yearly EPS VS EstimatesOZON Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -100 -200 -300

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OZON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OZON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OZON Price Earnings VS Forward Price EarningsOZON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.41
OZON Per share dataOZON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

OZON's earnings are expected to decrease with -46.97% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-87.19%
EPS Next 3Y-46.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OZON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Ozon Holdings PLC

NASDAQ:OZON (2/25/2022, 8:02:43 PM)

Premarket: 9.4 -2.2 (-18.97%)

11.6

-1.03 (-8.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryInternet & Direct Marketing Retail
Earnings (Last)N/A N/A
Earnings (Next)04-12 2022-04-12/bmo
Inst Owners0%
Inst Owner Change-98.04%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.51B
Analysts77
Price Target44.53 (283.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.38
P/FCF N/A
P/OCF N/A
P/B 4.29
P/tB N/A
EV/EBITDA -5.41
EPS(TTM)-2.74
EYN/A
EPS(NY)-4.04
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.38
BVpS2.71
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -28.12%
PM (TTM) -30.33%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.67
Altman-Z 0.72
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-217.21%
EPS Next Y-182.2%
EPS Next 2Y-87.19%
EPS Next 3Y-46.97%
EPS Next 5Y-21.7%
Revenue 1Y (TTM)70.96%
Revenue growth 3Y67.44%
Revenue growth 5YN/A
Sales Q2Q%84.93%
Revenue Next Year74.83%
Revenue Next 2Y72.82%
Revenue Next 3Y64.59%
Revenue Next 5Y62.13%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A